Professor Sarah Tabrizi (ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûInstitute of Neurology) is leading the trial of a new drug that might slow the progression of Huntington's disease. Research byÌýProfessor Gill Bates (ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûInstitute of Neurology) is also mentioned and Dr Ed Wild and Professor John Hardy (ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûInstitute of Neurology) are quoted.